Shasun Pharma jumps on successful MHRA EU inspection
Published: 30th August 2013 12:18 PM
Last Updated: 30th August 2013 12:18 PM
Shasun Pharmaceuticals rallied on Friday after the company said
it has successfully completed MHRA inspection during the third week
of August 2013. The main focus of the inspection was to conduct
cGMP audit for the formulation facility.
On completion of inspection, the MHRA authorities concluded
that, the facility, system and practices comply with MHRA
requirements, the company said.
Shares ofthe companyare trading at Rs
62.45, up Rs 3.75, or 6.39% at the Bombay Stock Exchange (BSE) on
Friday at 11:26 a.m.The scrip has touched an intra-day high of Rs
64.40 and low of Rs 59.05. The total volume of shares traded at the
BSE is 88,064.In the earlier session, the shares gained 0.77%, or
Rs 0.45, at Rs 58.70. Currently, the stock is trading down 66.41%
from its 52-week high of Rs 185.90 and above 36.95% over the
52-week low of Rs 45.60.
Share Price Movement Period Pricein Rs
Gain/(Loss) in Rs in % 1 Week 64.40 (9.60) (14.91) 1 Month 75.05
(20.25) (26.98) 3 Months 63.75 (8.95) (14.04) 6 Months 143.50
(88.70) (61.81) 1 Year 116.20 (61.40) (52.84) Note: Based on
previous day closing price.